SCHEMBL18377044

SCHEMBL18377044

COc1ccc(-c2cccc3cnc(Nc4cccc(S(C)(=O)=O)c4)nc23)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RIPK2 O43353 8/20 0.69
▸ ACVR1 Q04771 4/20 0.54
▸ CDK9 P50750 2/20 0.54
▸ AURKA O14965 1/20 0.54
▸ MAP4K4 O95819 1/20 0.54
▸ ABL1 P00519 1/20 0.54
▸ LCK P06239 1/20 0.54
▸ MET P08581 1/20 0.54
▸ PDGFRB P09619 1/20 0.54
▸ FGFR1 P11362 1/20 0.54
▸ FLT1 P17948 1/20 0.54
▸ KDR P35968 1/20 0.54
▸ FLT3 P36888 1/20 0.54
▸ MAPK8 P45983 1/20 0.54
▸ MAPK9 P45984 1/20 0.54
▸ GSK3A P49840 1/20 0.54
▸ GSK3B P49841 1/20 0.54
▸ CDK5 Q00535 1/20 0.54
▸ MST1R Q04912 1/20 0.54
▸ TYRO3 Q06418 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29372255 1.00 RIPK2 (0.69) RIPK2ACVR1CDK9AURKAMAP4K4
SCHEMBL18376613 0.90 JAK2 (0.59) RIPK2ACVR1CDK9AURKAMAP4K4
SCHEMBL18377049 0.90 RIPK2 (0.57) RIPK2KDRCLK4PTK2JAK2
SCHEMBL29370809 0.87 PIK3CG (0.60) RIPK2KDRCDK5CLK4PTK2
SCHEMBL18377040 0.87 PIK3CG (0.60) RIPK2KDRCDK5CLK4PTK2
SCHEMBL18377036 0.84 MAPK10 (0.55) RIPK2AURKAKDRMAPK8CCNE1
SCHEMBL29371938 0.84 MAPK10 (0.55) RIPK2AURKAKDRMAPK8CCNE1
SCHEMBL18376750 0.84 MAPK10 (0.60) RIPK2AURKAKDRCDK5PTK2
SCHEMBL29371294 0.84 MAPK10 (0.60) RIPK2AURKAKDRCDK5PTK2
SCHEMBL18376254 0.84 RIPK2 (0.56) RIPK2CDK9PDGFRBGSK3BJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN claimed
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 — — CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN disclosed
CN-106316965-B Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2021-08-27 — — CN disclosed
WO-2017005137-A1 QUINAZOLINE COMPOUND, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF 吉林大学 2017-01-12 — — WO disclosed
Send feedback